Extendicare Inc. (TSE:EXE – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven research firms that are covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is C$18.10.
A number of equities analysts recently issued reports on the company. TD Securities upped their price target on Extendicare from C$15.00 to C$19.00 in a report on Thursday, November 13th. Cibc World Mkts upgraded shares of Extendicare to a “strong-buy” rating in a research report on Monday, September 22nd. National Bankshares increased their target price on shares of Extendicare from C$16.10 to C$17.50 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. BMO Capital Markets lifted their price target on shares of Extendicare from C$15.00 to C$21.00 in a research note on Monday, November 17th. Finally, CIBC boosted their price target on shares of Extendicare from C$18.00 to C$22.00 in a research report on Thursday, November 13th.
Check Out Our Latest Stock Analysis on EXE
Extendicare Trading Up 1.6%
Extendicare Announces Dividend
The company also recently announced a monthly dividend, which was paid on Monday, November 17th. Stockholders of record on Monday, November 17th were issued a $0.042 dividend. This represents a c) annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Friday, October 31st. Extendicare’s payout ratio is presently 46.60%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
- Five stocks we like better than Extendicare
- Stock Splits, Do They Really Impact Investors?
- MP Materials Stock Soared After Earnings—Here’s the Real Reason
- How Can Investors Benefit From After-Hours Trading
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
- What is MarketRank™? How to Use it
- Attention Income Investors: This REIT Is on Sale
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
